Off to a good start: the influence of pre- and periconceptional exposures, parental fertility, and nutrition on children's health. by Chapin, Robert E et al.
There is a growing appreciation of the impact
that very early life environment (birth weight,
trauma, xenobiotic exposures) has on the
health of the child and the adult. The life-
course approach to health and disease recog-
nizes that these very early impacts contribute
to disease later in life (reviewed in Gillman
2002). From this perspective, any long-term
prospective study that attempts to uncover
and identify effects on children’s health
should include an evaluation of the health of
both parents prior to and at the time of con-
ception, including xenobiotic load, nutritional
state of the mother, and the involvement of
any assisted reproductive technologies. These
features have already been shown to have
demonstrable short-term impacts on the
health of the child. Long-term follow-up is
essential if we are to fully understand the
health burden attributable to these features
and to develop more informed hypotheses
about exposure–disease relationships. Only
from such a complete picture can we hope to
make policy decisions that will use our
resources most effectively to improve the
health of generations to come.
Although by no means an exhaustive
review, this article presents some of what we
know about these impacts. We conclude that
explicit assessment of such exposures and fac-
tors before and around the time of conception
is indispensable for a real understanding of the
determinants of health in our children, and,
by extension, the next generation of adults.
The Case for Early Analyses
Explicit measurements of exposure, body
burden, or nutritional status in a couple
before conception is necessary for numerous
reasons.
One critical reason is that recall is variably
dependable. Some studies found that the abil-
ity of a person to recall speciﬁc exposures was
good to excellent for some medications
(reviewed in Harlow and Linet 1989; Kelly
et al. 1990) and some environmental expo-
sures and pesticides (Blair et al. 2001;
Feldman et al. 1989) but no better than
chance for others (Feldman et al. 1989; Kelly
et al. 1990). Although multiple question-
naires may increase the likelihood of obtain-
ing an accurate picture of what the exposures
truly were (Farrow et al. 1996), this can be
cumbersome and may yield a relatively small
increase in conﬁdence.
Additionally, questionnaires have a signiﬁ-
cant limitation: they capture only what is
remembered, which can come only from what
the participant knows or is aware of.
Importantly, environmental exposures are
occult. Exposures to and absorption of excipi-
ents and active agents from manufactured
products frequently occur without our knowl-
edge or awareness. Phthalates in air or cosmet-
ics can lead to measurable levels in vivo, for
example (Blount et al. 2000), an internal
exposure that no questionnaire, however well
constructed and administered, would be able
to ﬁnd and reconstruct. Speciﬁc phthalates are
capable of disrupting reproductive develop-
ment in rodents (reviewed in CERHR 2002)
and are suspected of causing similar effects in
other species, so this gap in our understanding
is critical. The limitations of questionnaire
data were demonstrated recently for polychlo-
rinated biphenyls (PCBs), where there was no
association between potential sources of expo-
sure by questionnaire and actual serum levels
of several coplanar PCBs (Shadel et al. 2001).
Because few consumers are aware of their
exposures or the sources thereof, questionnaire
data will not be useful for categorizing study
subjects into most-exposed and least-exposed
groups for many compounds of current (and
probably future) concern.
Arguably, one of the best reasons for per-
forming a prospective longitudinal study is
the high probability of finding new associa-
tions between previously unanticipated expo-
sures and a health outcome. The more we
know about what compounds are in the body
and in what amounts, the greater our confi-
dence will be in associating those exposures
with health outcomes. This accuracy cannot
be acquired with questionnaire proxy data,
but requires actual measurements as well as
measurements of compounds beyond those
that we know today to be hazards.
Making concurrent measurements of
body burden is important because of the
changing nature of xenobiotics. One of the
results of phasing out persistent organic pol-
lutants is that more xenobiotics now have
shorter half-lives, and a biological sample
taken in late pregnancy or after birth cannot
be considered representative of in vivo levels
at the time of conception or during early
pregnancy (reviewed in MacIntosh et al.
1999). An excellent example is methoxychlor,
developed to replace dichlorodiphenyl-
trichloroethane (DDT). It has a similar spec-
trum of intended effects but is much more
readily excreted and thus has a much-reduced
tendency to bioaccumulate (Kapoor et al.
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Whence Healthy Children? | Mini-Monograph1970). Phthalates are another example: these
are cleared from the body with relative speed
(several days to a few weeks) and do not
bioaccumulate significantly (Tanaka et al.
1978). From the public health and environ-
mental perspectives, this is incontrovertibly
good, although it means that actually deter-
mining which levels of which compounds are
adverse requires repeated biological sampling
and analysis.
A corollary of these short half-lives is con-
siderable sample-to-sample variation. Even
with no obvious changes in behavior, urinary
levels of some pesticides have been shown to
vary by factors of four times or more
(MacIntosh et al. 1999). Consequently, a sin-
gle sample will be poorly representative of the
long-term levels in that individual.
A benefit of repeated sampling is that it
would accommodate the altered behaviors
exhibited by women when they know they are
pregnant (Lelong et al. 2001; Root and
Browner 2001). If these altered behaviors also
reduced their exposures to, and internal bur-
dens of, harmful xenobiotics, then the
reduced internal half-lives plus the altered
behaviors will significantly reduce internal
levels, making late-stage analyses even less
representative of earlier levels. Measuring
internal levels of xenobiotics around the time
of conception will provide a much more real-
istic picture of the exposure of the embryo at
the critical period of conception.
Study of the nutritional status of a
woman prior to pregnancy would allow for
the timely measurement of prepregnancy
weight and the collection of dietary history
and laboratory data. Studies have found that
self-reported prepregnancy weight may be
biased, especially among overweight women,
who are more likely to underestimate their
prepregnancy weight (Perry et al. 1995;
Stevens-Simon et al. 1986). Dietary deﬁcien-
cies, thought to be due to long-standing
dietary habits and not a sudden insult, may
resolve if a woman changes her diet after she
knows that she is pregnant. By getting a
dietary history prior to conception, we can
eliminate recall bias and document diet dur-
ing the critical periods (Sempos 1992; Wei
et al. 1999). Early collection of laboratory
data is important for several reasons. First,
hemodilution, which begins early in the sec-
ond trimester and varies in degree and timing
among individuals, makes interpretation of a
number of micronutrient levels difﬁcult (e.g.,
plasma zinc concentrations). Second, other
physiologic changes that occur during preg-
nancy (e.g., increased renal excretion of
water-soluble vitamins, hormone-mediated
transfer of nutrients to placenta and mam-
mary glands, decrease of serum albumin)
make determining micronutrient status during
pregnancy difficult (King 2000). Third, it
may be important to measure micronutrient
levels prior to pregnancy because changes in
behavior (e.g., cessation of smoking and/or
alcohol consumption) and use of iron and
multivitamin supplements during pregnancy
may affect laboratory values. Last, changes in
the type and quantity of food consumed as
well as changes in physical activity may affect
values (King 2000). By evaluating nutritional
status prior to pregnancy or in early preg-
nancy prior to physiologic and behavioral
changes, one can more accurately evaluate a
woman’s nutritional status and the associa-
tions between nutritional status during early
pregnancy and subsequent functional out-
comes. Knowledge of such associations could
lead to interventions that prevent adverse out-
comes, such as the provision of folic acid to
prevent birth defects.
The rest of this review will focus on a
variety of key issues and their relationships to
the health of the resultant child: compounds in
semen; compounds in the prepregnant female;
the effects of assisted reproductive technologies
(ARTs); the effects of preimplantation expo-
sures; the influence of early maternal nutri-
tion; and a review of the period of greatest
sensitivity for producing malformations and
fetal alterations.
Compounds in Semen
The pathway through which environmental
toxicants contaminate semen and affect off-
spring is diagrammed in Figure 1. In this sce-
nario, a male is exposed to an environmental
toxicant that is absorbed, distributed, biotrans-
formed, and excreted as metabolite or parent
compound in seminal fluid. Alternatively,
compounds can be adsorbed to sperm and be
introduced directly into the egg at fertilization
[e.g., cocaine or cyclophosphamide (reviewed
in Hales and Robaire 2001; Yazigi et al.
1991)]. Any contaminants in semen are trans-
mitted to a woman in the ejaculate. The cont-
aminant is absorbed by the female, where it
may reach and adversely affect a current preg-
nancy and perhaps remain in the woman’s
body to influence future pregnancies, or it
enters the egg with the sperm and provides an
initial direct dosing of the conceptus.
Teratogenic, carcinogenic, and endocrine-
disrupting agents have all been detected in
human seminal ﬂuid. For example, pesticide
residues including the dioxin congener
2,3,7,8-tetrachlorodibenzo-p-dioxin, hexa-
chlorocyclohexane isomers (as prevalent as
100% in some populations tested), DDT and
its metabolites, and 2,4-dichlorophenoxyacetic
acid have been identified and quantified in
seminal plasma (Arbuckle et al. 1999; Kumar
et al. 2000; Pflieger-Bruss and Schill 2000;
Schecter et al. 1996; Schlebusch et al. 1989;
Stachel et al. 1989; Szymczynski and
Waliszewski 1981; Wagner et al. 1990).
Metals such as lead and cadmium, both
known developmental toxicants, have been
measured in human seminal ﬂuid by a num-
ber of research groups (Dawson et al. 2000;
Kumar et al. 2000; Noack-Fuller et al. 1993;
Saaranen et al. 1989; Stachel et al. 1989;
Telisman et al. 2000; Xu et al. 1993). The
organic solvents benzene, toluene, and xylene
can be found in semen (Xiao et al. 1999), and
ethanol can be detected, entering through sim-
ple diffusion (Luke and Coffey 1994). Finally,
seminal ﬂuid of smokers contains nicotine, its
metabolites, aromatic hydrocarbons, and pre-
cursors of mutagenic nitrosamines (Hoffman
et al. 1994; Paciﬁci et al. 1993; Rivrud 1988;
Wong et al. 2000). The critical question of
dose sufﬁciency (are these compounds present
at a level sufficient to cause adverse effects?)
remains unanswered.
The composition of seminal ﬂuid changes
normally as a function of frequency of ejacu-
lation, hydration, nutritional state, and expo-
sures to the male. Because of this variability, it
would be necessary to monitor the ﬂuid in a
prospective way to make clear associations
between contaminants present in seminal
fluid (and transmitted to a female partner)
and any abnormalities in the offspring. Only
recently have laboratories been capable of
measuring multiple low-concentration conta-
minants in ever-smaller amounts of seminal
fluid. This capability presents a significant
opportunity. A large longitudinal study, cou-
pled with advances in detection and measure-
ment of chronic, low-level contaminants in
seminal fluid, would provide an excellent
opportunity to more clearly delineate any
associations between semen-mediated very
early exposures and health outcomes in
the offspring.
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Figure 1. Schematic of possible pathway of exoge-
nous agents that could directly affect the concep-
tus via nonsperm contributions from the male.
Exposure of adult male to teratogen
Transmitted to female in the ejaculate
Absorbed by female or the ovum
Affects current or future pregnancies
Teratogen absorbed and secreted
in seminal fluidAltered Semen Quality
An important area often neglected when
evaluating environmental exposures and chil-
dren’s health relates to sperm DNA–derived
effects. Exposures to the father that cause
germline DNA or chromatin damage and
consequently affect offspring health are well
documented in animal models (reviewed in
Hales and Robaire 2001). Similar studies in
humans (exposing the male to toxicants, mat-
ing over time, monitoring offspring for
adverse effects) cannot even be approached
for obvious ethical reasons. Yet, there is
undisputed evidence that the human male
signiﬁcantly affects the health of his children
through sperm DNA in paternally mediated
Mendelian genetic defects, chromosomal
aberrations (e.g., paternal translocation carri-
ers), and aneuploid sperm (associated with
30–50% of Klinefelter, 80% of Turner, 5%
of Down, and 100% of extra Y chromosome
syndromes) (Blanco et al. 1998; Eskenazi
et al. 2002; Hassold 1998; Hixon et al. 1998;
Martinez-Pasarell et al. 1999; Pangalos et al.
1992). Researchers in ART clinical settings
have shown that both paternal sperm chro-
matin and DNA quality affect pre- and
postimplantation development of offspring
(Evenson et al. 2002; Hammadeh et al. 1996;
Tesarik et al. 2002). It is evident that sperm
with abnormalities of DNA and/or chromatin
are able to fertilize and transmit abnormal
DNA to the conceptus. It is also evident from
numerous studies that environmental expo-
sures can induce mutations, chromosomal
aberrations, chromatin, or epigenetic protein
changes in human sperm (selected examples
in Table 1). This leads to a model for envi-
ronmentally induced male-mediated effects
on offspring, as depicted in Figure 2. This
model clearly demonstrates the importance of
a study design that monitors environmental
exposures to the father during sperm develop-
ment and maturation prior to and at the time
of fertilization. Because sperm are constantly
being replenished in the male genital tract,
only prospective study designs are able to cap-
ture direct effects of environmental exposures
on sperm DNA quality at the time of concep-
tion. Previous studies that have tried to estab-
lish cause–effect relationships by evaluating
DNA quality of sperm after the birth of an
abnormal child have not been successful
because of this temporal flaw. Recent
advances in molecular-cell and genetic labora-
tory techniques now allow sophisticated
assessment of human sperm DNA and chro-
matin damage (Evenson et al. 2002; Perreault
et al. 2000, 2003). There are new under-
standings of the critical role of sperm chro-
matin organization and paternal DNA in
early embryo development (Evenson 1999;
Sakkas et al. 1998; Tesarik et al. 2002). A
prospective longitudinal study would be the
most deﬁnitive way to ﬁnally answer the ques-
tion of dose, timing, and types of exposures
that cause speciﬁc sperm DNA and chromatin
damage that affects offspring health.
Compounds in the Female
In addition to the father’s contribution, the
mother brings a time-averaged and complex
body burden of xenobiotics to the conception
and the early pregnant period.
What is known about the effects of com-
pounds at this time is recent and relatively
limited. This is partly because earlier studies
examining the impact of these exposures in
the environmental setting and reproductive
effects were severely hampered by crude meas-
ures of exposure. Lack of biological assays to
measure many of these contaminants in tissue
specimens, the high cost of using these assays
in large epidemiologic studies when they were
available, and challenges related to the inter-
pretation of the results when exposures were
measured after the adverse reproductive event
occurred limit the conclusions that can be
drawn from these investigations. Rapid
advancements in laboratory techniques,
including biological assays as screening
methods for exposure to these contaminants,
as well as highly sensitive techniques to meas-
ure specific congeners of the compounds or
their metabolites at reasonable costs are excit-
ing developments that hold great promise in
enhancing our understanding of the impact of
these exposures on reproductive events
(Humphrey et al. 2001; Seidel et al., 2000).
Despite these impediments, data do exist
from national studies to describe general
population exposures to some of these conta-
minants. The National Health and Nutrition
Examination Survey II (NHANES II) meas-
ured serum levels of selected pesticides in
approximately 21,000 participants ranging in
age from 12 to 74 years (Murphy and Harvey
1985). Increasing age was related to the pres-
ence of detectable levels of DDT, with the
proportion exposed ranging from 14 to 51%
across the age spectrum. Serum values ranged
from 2 to 58 ppb. Detectable levels of the
DDT metabolite p,p´-DDE were found in
serum in nearly 99% of the population, with
values ranging from 1 to 378 ppb, which also
increased with age.
Although the use of DDT in the United
States has been banned for more than
30 years, exposure may continue through
consumption of contaminated foods, includ-
ing products imported from countries where
DDT is still being used, as well as foods con-
taminated because of the environmental per-
sistence of DDT. Additional data on serum
DDE levels in selected subgroups from the
U.S. population are available from several
investigations that were conducted to exam-
ine the effect of DDE and PCB exposure and
risk of breast cancer. A recent study involved
the pooling of ﬁve U.S. studies that included
women over an interval spanning 1974–1997
(Laden et al. 2001). Median values for serum
DDE levels ranged from 0.41 to 1.67 µg/g
lipids. Several studies have also assessed DDE
levels among consumers of sport-caught fish
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Table 1. Evidence that selected environmental exposures are associated with DNA, chromatin, or epigenetic
damage in human sperm.
Selected Genetic or epigenetic
environmental exposures damage in human sperm Author/year
Organophosphate pesticides Aneuploidy Recio et al. 2001
Padungtod et al. 1999
Tobacco smoke DNA strand breaksa Potts et al. 1999
Acid-labile DNA sites Potts et al. 1999
Benzo[a]pyrene diol epoxide adducts Zenzes et al. 1999
8-Hydroxydeoxyguanosine Fraga et al. 1996
Aneuploidy Robbins et al. 1997
Rubes et al. 1998
Harkonen et al. 1999
Air pollution Aneuploidy Robbins et al. 1999
Acid-labile DNA sites Selevan et al. 2000
1,3-Butadiene metabolites DNA strand breaks Anderson et al. 1997
Ethylene glycol monomethyl ether DNA strand breaks Anderson et al. 1997
Lead DNA strand breaks Anderson et al. 1997
aSergerie et al. (2000) did not ﬁnd an association between smoking and DNA strand breakage.
Figure 2. Schematic of pathway of sperm-mediated
effects on offspring health and development.
Germline mutations, unrepaired DNA
damage, epigenetic and protein damage
Environmental exposure (fertile male)
Affected sperm
Affected offspring: birth defect, cancer,
chronic disease, infertilityfrom contaminated waters (Hanrahan et al.
1999; Schantz et al. 2001). These reports
indicate that consumers of sport-caught fish
have higher serum DDE levels compared with
those of nonconsumers (Hanrahan et al.
1999; Schantz et al. 2001).
These same studies in consumers of sport-
caught fish versus nonconsumers have pro-
vided data on serum PCB levels among
consumers compared with non–fish-eaters.
Background PCB levels in the U.S. population
were reported to be 4–8 ppb in the early 1980s
(Kreiss 1985) and is currently 0.9–2.2 ppb
(ATSDR 2000). In the Hanrahan study con-
ducted in 1993–1994, male ﬁsh-eaters had a
mean serum PCB level of 4.8 ppb compared
with 1.5 ppb among their nonconsuming
counterparts (Hanrahan et al. 1999), whereas
female ﬁsh-eaters had levels of 2.1 ppb versus
0.9 ppb among female non–fish-eaters.
Participants in the Michigan ﬁsh-eaters cohort,
which consists of individuals who were con-
suming ≥ 26 pounds of sport-caught ﬁsh per
year (ﬁsh-eaters) and those eating < 6 pounds
per year (non–fish-eaters), when enrolled in
1980, had considerably higher serum PCB
levels (Tee et al. 2003).
How do these maternal burdens impact
the developing fetus or child? In a cohort of
infants born to Michigan women in 1983 that
included consumers of sport-caught ﬁsh and
those who ate ﬁsh other than sport caught, sig-
nificantly lower birth weight and delayed
motor reflexes were noted among exposed
infants at birth (Fein et al. 1984). Overall,
mean PCB levels in cord blood PCB in this
study were 3 ng/mL (± 2 ng/mL), and in
maternal serum 6 ng/mL (± 4 ng/mL).
Importantly, persistent effects on cognitive
functioning among the exposed children were
reported in a follow-up at 11 years of age
(Jacobson and Jacobson 1996). This increased
burden tends to weigh most heavily on lower
socioeconomic minority populations (Sweeney
et al. Unpublished data), and these increased
exposures bring adverse consequences. Only
by determining with certainty the different
exposures during development and following
many outcomes postnatally can we ascertain
the full burden of these exposures, which is
the ﬁrst step toward their elimination.
Other examples of endocrine-active
compounds (EACs) that have been detected in
serum and adipose tissue samples obtained
from representative populations from the
United States include beta-benzene hexa-
chloride, dieldrin, trans-nonachlor, hexachloro-
benzene, heptachlor epoxide, and oxychlordane
(Murphy and Harvey 1985). Another class of
EACs measured in NHANES III, the phtha-
lates, has generated considerable concern
regarding potential adverse reproductive effects.
Using a novel and highly selective technique,
investigators measured monoester metabolites
of seven commonly used phthalates in
289 adults from the NHANES III study popu-
lation (Blount et al. 2000). An important ﬁnd-
ing of this study was the significantly higher
urinary levels of monobutyl phthalate among
women of reproductive age compared with
those of other age/gender groups. In addition,
rural women of childbearing age had higher
levels of benzyl butyl phthalate compared with
those of older rural women. This is of concern
because both of these phthalate isomers have
been implicated in animal studies of reproduc-
tive toxicity (Gray 1998; Jobling et al. 1995;
Shiota et al. 1980; Wilkinson and Lamb 1999).
Human studies are scarce, but a recently pub-
lished case–control study examined the associa-
tion between premature thelarche (premature
breast development) and phthalate exposure
among girls 6 months to 8 years of age (Colon
et al. 2000). With serum as the medium, signif-
icantly higher levels of dimethyl, diethyl,
dibutyl, and di-2-ethylhexyl phthalate (DEHP)
were measured in the cases. With regard to
DEHP, the ratio of average concentrations
between control:case samples was 70:450 ppb.
Animal studies show that DEHP has its greatest
effects while the reproductive system is forming
(within the first 4 weeks in a human preg-
nancy), so identifying and quantifying phtha-
late levels prepregnancy will be particularly
important in ensuring that all the impacts on
reproductive development are accounted for
and quantiﬁed.
Finally, although not classified as EACs,
lead and mercury are important environmen-
tal contaminants associated with adverse
effects on reproduction. Although an elevated
lead level in children is deﬁned as > 10 µg/dL
by the Centers for Disease Control and
Prevention (CDC 2000), a “safe” lead level
remains controversial (Sanborn et al. 2002).
As with PCB levels, blood lead levels in the
United States have been steadily declining.
However, subgroups, particularly low-income
populations and children requiring social ser-
vices and foster care, remain at high risk for
elevated blood lead levels (Chung et al. 2001).
Organic mercury, which is mostly methyl
mercury, bioaccumulates in the aquatic food
chain and can be present in relatively large
amounts in fish living in contaminated
waters. Effects on the developing nervous sys-
tem have been well documented in studies
following the Minamata Bay and Iraq poison-
ing incidents (reviewed in CDC 2000), as
well as in more recent studies of children
exposed prenatally at much lower levels
(Grandjean et al. 1998). A recent report
issued by the National Research Council
estimates that 60,000 infants per year in the
United States may be prenatally exposed to
levels of methyl mercury sufficient to cause
neurological and cognitive impairments
(National Research Council 2000).
Concern has also focused (Toppari et al.
1996) on the possible role of endocrine-
disrupting chemicals with either estrogenic or
antiandrogenic effects in the marked rise
(almost doubling) in the prevalence of
hypospadias in the United States and Europe
since the late 1960s (Kallen et al. 1986;
Paulozzi et al. 1997). Because the develop-
ment of the male genital organs is under hor-
monal control, the main hypotheses as to the
etiology of hypospadias are centered on either
disturbance of endogenous hormonal produc-
tion or exposure to exogenous hormones
(Dolk 1998). The hypothesis is supported by
the most recent ﬁndings of an increased risk
of hypospadias in sons of women who them-
selves had been prenatally exposed to diethyl-
stilbestrol (DES; a synthetic estrogen widely
prescribed to pregnant women between 1938
and 1975 to treat habitual abortions) (Klip
et al. 2002). This transgenerational effect was
associated with maternal in utero exposures to
DES early in the first trimester. A link with
cryptorchidism has also been noted. Because
the reproductive system forms early in the
ﬁrst trimester, obtaining the best possible esti-
mates of exposure during that time will help
us determine the degree of environmental
contribution to these problems.
Early first-trimester drug exposures have
been linked to birth defects. Recent examples
are the illicit use of amphetamines associated
with significantly increased risk of predomi-
nantly cardiovascular and musculoskeletal
malformations (McElhatton et al. 1999), and
the misuse of misoprostol, a synthetic analog
of prostaglandin E, resulting in limb deformi-
ties attributable to vascular disruption
(Gonzales et al. 1998).
Adverse developmental outcomes have also
been associated with early exposures to envi-
ronmental physical factors. Pre- and pericon-
ceptional parental occupational exposures to
low-level ionizing radiation have been repeat-
edly associated with increased risk of fetal loss
and neural tube defects (NTDs) (Doyle et al.
2000; Inskip 1999; Sever et al. 1988).
Given the findings above and the recent
quantitation of a number of xenobiotics in
human ovarian follicular ﬂuid (Younglai et al.
2002), the impact of these environmental
chemicals on human reproduction has become
a high priority for public health researchers
(Barlow et al. 1999). A paper describing the
conclusions reached by the recent U.S.
Environmental Protection Agency–sponsored
“Workshop to Identify Critical Windows of
Exposure for Children’s Health” called for
research into the effects of environmental
exposures during the periconceptional and pre-
natal periods on reproductive and children’s
health (Pryor et al. 2000). With advances in
laboratory techniques and statistical modeling
approaches for exposure assessment, we are
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degree of exposure that occurs early, which will
affect strategies for preventive health policies in
the future.
Assisted Reproductive
Technologies
The evolution of and increasing use of various
ARTs for the treatment of infertility has pro-
vided additional insight into the importance
of considering exposures that occur very early
in conception or even just prior to conception.
ART encompasses those procedures in which
both eggs and sperm are handled in the labo-
ratory. To date, a range of effects have been
reported in association with various facets of
ART procedures. Some effects can be linked
to speciﬁc exposures that occur in conjunction
with a particular step in the ART cycle; for
other effects, an association with ART is sug-
gested, but it is not possible from available
data to disentangle the specific exposures or
mechanisms. Nonetheless, the data accumulat-
ing from ART pregnancies underscore the
importance of periconceptional exposures.
The vast majority of ART procedures
include ovarian stimulation with either
clomiphene citrate, human pituitary gonado-
tropins (various formulations), or both. Several
potential adverse effects have been suggested
from studies focusing on the use of these ovu-
lation-stimulating drugs. Perhaps the most
striking finding is the association reported
between artiﬁcial induction of ovulation and
monozygotic (MZ) twinning. Unlike dizygotic
twinning, the prevalence of MZ twinning has
been remarkably constant worldwide (Dunn
and Macfarlane 1996; Guttmacher 1953; Hur
et al. 1995; MacGillivray 1986; Parazzini et al.
1991). However, in the late 1980s, Derom and
colleagues reported a 2-fold increase in the MZ
twin birth rate among women from their pop-
ulation-based study in East Flanders, Belgium,
who had conceived after therapy with an ovu-
lation-inducing medication, compared with
the rate among women who conceived natu-
rally (Derom et al. 1987). This was the first
report that an extrinsic factor might affect
zygotic division. Because twinning carries a
suite of increased health risks (Kovacs et al.
1989; Naeye et al. 1978), this is not viewed as
a benign outcome. Use of ovulation drugs, par-
ticularly clomiphene, has also been implicated
as a risk factor for spontaneous abortion (Balen
et al. 1993; Dickey et al. 1996; McFaul et al.
1993; Oktay et al. 2000; Shoham et al. 1991),
preterm delivery (Olivennes et al. 1993;
Sundstrom et al. 1997) and low birth weight
(Olivennes et al. 1993; Sundstrom et al. 1997).
This research raises the question about whether
such medications might adversely affect
oocytes directly. Studies in mice suggest that
clomiphene might affect oocyte maturation
and rates of aneuploidy (London et al. 2000).
Perhaps the most obvious source of unique
exposures linked to ART pregnancies is the
culture media in which preimplantation
embryos are fertilized and cultured. A body of
both animal and human research is accumulat-
ing that implicates several factors in culture
media as having an effect on embryo develop-
ment. High concentrations of glucose in cul-
ture media have been associated with decreased
embryo quality, defined by cleavage rates,
degree of fragmentation, and blastocyst devel-
opment (Coates et al. 1999; Gardner et al.
2000). These effects were reported from stud-
ies of human embryos and embryos from sev-
eral other mammalian species and may be
mediated by altered intracellular pH (Bavistor
1999). Mouse embryos incubated in serum-
containing media had altered cleavage rates
compared with the rates in embryos cultured
in media without serum (Khosla et al. 2001).
Moreover, the addition of serum to culture
media has been linked to effects on DNA
methylation and deregulation of imprinted
genes. These findings have implications for
outcomes associated with imprinted genes,
such as those controlling fetal growth. Finally,
several case reports and studies have suggested
a general association between in vitro culture to
the blastocyst stage and MZ twinning (Behr
et al. 2000; da Costa et al. 2001; Gorrill et al.
2001; Peramo et al. 1999; Sheiner et al. 2001;
Van Langendonckt et al. 2000).
ART embryos might also be affected by
various techniques in which the embryos are
manipulated beyond in vitro culture. In intra-
cytoplasmic sperm injection (ICSI), a single
spermatozoon is directly injected into the egg
through the oocyte membrane. Studies on
embryos from various mammalian species
suggest that ICSI is related to a host of
chromosomal abnormalities including effects
on spindle apparatus, microtubules, chro-
matin behavior, cell cycle checkpoints, and
chromosome positioning (Hewitson et al.
1999; Luetjens et al. 1999; Ramalho-Santos
et al. 2000; Sutovsky et al. 1996; Terada et al.
2000). Increases in both de novo sex chromo-
some abnormalities and de novo autosomal
rearrangements have been reported among
infants conceived using ICSI (Bonduelle et al.
2002). The other, longer-term health changes
associated with this procedure have yet to
be evaluated.
Another embryo manipulation technique
that has raised concern is “assisted hatching”
(Alikani et al. 1994; Nijs et al. 1993; Skupski
et al. 1995; Slotnick and Ortega 1996;).
Comparative studies have documented an
increased risk for MZ twinning in ART preg-
nancies that included assisted hatching
(Hershlag et al. 1999; Schieve et al. 2000), and
animal studies have shown that MZ twinning
can be induced through mechanical or chemical
manipulation of the zona pellucida (Allen and
Pashen 1984; Picard et al. 1985; Sotomaru et
al. 1998; Talansky and Gordon 1988).
Infant outcomes have also been linked to
ART generally. ART is recognized as an
important contributor to the U.S. low birth
weight rate because of the known associations
between ART and multiple birth (CDC
2002a, 2002b) and between multiple birth
and low birth weight (Martin and Park
1999). Additionally, studies have suggested
that low birth weight rates are increased
among singleton infants conceived with
ART compared with naturally conceived
infants or population-based rates (Bergh et al.
1999; Dhont et al. 1999; FIVNAT 1995;
Friedler et al. 1992; Gissler et al. 1995; MRC
Working Party 1990; Schieve et al. 2002;
Verlaenen et al. 1995; Westergaard et al.
1999). Additional analysis suggests that the
increased risk for term low birth weight may
be related to the ART procedure itself rather
than the underlying infertility.
Equivocal results have been reported for
the association between ART and birth
defects in the offspring (Bergh et al. 1999;
Bonduelle et al. 2002; Dhont et al. 1999;
Ericson and Kallen 2001; FIVNAT 1995;
Friedler et al. 1992; Hansen et al. 2002;
MRC Working Party 1990; Verlaenen et al.
1995; Wennerholm et al. 2000; Westergaard
et al. 1999). Studies to date have suffered
from various methodological problems,
including low statistical power, particularly to
assess individual defects separately, and differ-
ential case ascertainment and coding schemes
for infants conceived using ART and infants
conceived naturally. Nearly all studies relied
on retrospective registry data. Two recent
studies have shown increased risk for various
birth defects among ART-conceived infants
(NTDs, alimentary tract atresia, omphalocele,
hypospadias, and cardiovascular, urogenital,
chromosomal, and musculoskeletal defects)
(Ericson and Kallen 2001; Hansen et al.
2002). These studies are particularly notewor-
thy because they demonstrated elevated risks
even among singleton infants. A longitudinal
prospective study that looks at long-term out-
comes would be immensely valuable in delin-
eating yet-undiscovered associations between
long-term health and method of conception.
These concerns are made more acute by a
recent study that reported an increased risk for
developmental delay and cerebral palsy among
children conceived with ART (Stromberg
et al. 2002). These effects remained elevated
when analyses were limited to singleton births,
although the study suffered from a number of
methodological drawbacks, including a lack
of statistical power to adequately assess
subgroup ﬁndings.
Collectively, these data show that ART
methods have health consequences for the
offspring. Most of these studies have been
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to evaluate correlations between early proce-
dures and exposures, and later health out-
comes. Given that this much is already
known about health effects of ART, we
expect that more relationships would be
found if we evaluated health over a longer
term. A large longitudinal study would be
uniquely suited to define these relationships
and would help prospective parents to make
fully informed decisions about the true costs
and burdens of ART methods.
Preimplantation and Early
Gestational Exposures
Implantation in humans is a gradual process
that takes up most of the second week of preg-
nancy (reviewed in O’Rahilly and Muller
2001). In rats and mice, implantation occurs
between days 4 and 6 (reviewed in Cummings
1993). Although organogenesis was believed
to be the most vulnerable time for inducing
terata (see below), some recent studies have
found that preimplantation exposures can
have serious impacts on fetal health.
The ﬁrst example of this, ethylene oxide,
was reported by Generoso et al. (1987).
Subsequently, that same group reported that a
number of chemicals are potent teratogens
when administered to mice 1–6 hr after mat-
ing but are ineffective either before or after
that window (reviewed in Rutledge et al.
1992). In addition, the microtubule disruptor
nocodazole reportedly can disrupt midgesta-
tion development when administered only at
the time of sperm entry (Generoso et al.
1989). The authors conclude that there are
primarily epigenetic mechanisms at work.
Subsequently, cyclophosphamide, actino-
mycin D, methyl mercury, alkylating agents,
cross-linkers, and direct and indirect mutagens
have all been found to cause malformations or
growth alterations in offspring when adminis-
tered to pregnant rodents prior to implantation
(Iannaccone et al. 1987; reviewed in Rutledge
et al. 1992).
Less extreme exposures have effects in
humans. Parental periconceptional smoking,
for example, was associated with a signiﬁcant
decrease in offspring male:female ratio. In a
study on 11,815 singleton infants delivered in
Japan (Fukuda et al. 2002), the daily parental
consumption of cigarettes during the pericon-
ceptional period (from 3 months before the
last menstruation to when the pregnancy was
confirmed) was associated with a significant
decline in the neonatal male:female ratio.
This study fits into the larger picture of
the male:female newborn ratio decline in a
number of industrialized countries during
the past decades, including Denmark,
the Netherlands, Norway, Finland, Sweden,
Germany, Canada, and the United States
(Davis et al. 1998). The reason for this
reduction is not clear, but it has been
suggested that chronic exposures to toxic envi-
ronmental agents that predominantly affect
males and the male reproductive system could
lead to a lower male:female ratio, as seen, for
example, after the exposures to dioxins in
Seveso, Italy (Mocarelli et al. 2000), PCBs and
dibenzofurans in Taiwan (Rogan et al. 1999),
DBCP in Israel (Potashnik et al. 1984), med-
ical radiation (Hama et al. 2001), and methyl
mercury in Minamata Bay (Sakamoto et al.
2001). Evidence has emerged that mammalian
sex ratio at birth is partially controlled by
parental hormone levels at the time of concep-
tion (James 1996). These levels could be
altered by exposures to endocrine-active sub-
stances such as exogenous estrogens or by
compounds that interfere with a normal hor-
mone’s actions. Thus, the raised concentration
of human chorionic gonadotrophin during the
ﬁrst trimester of pregnancies complicated by
hyperemesis has been implicated as a reason
for the lower male:female ratio found in such
pregnancies compared with normal ones
(Sorensen 2000). Although these birth ratios
may normalize with time, if the sex ratios are
related to hormone levels at conception, they
may one day be considered a biomarker of
internal hormone status. A large prospective
study measuring hormone levels and postnatal
health (as well as gender) will be one way to
test this hypothesis.
It is plausible that some proportion of the
adverse health effects seen in some children
could be the result of yet-to-be-recognized
preimplantation exposures. Only by actually
determining what’s “on board” the mother
around the time of conception and implanta-
tion can we identify those inﬂuences.
Maternal Nutritional Status
Maternal nutrition is thought to be an under-
lying determinant of a variety of pregnancy
outcomes. A growing body of literature has
established the association between maternal
nutritional status and adverse pregnancy out-
comes (Luke 1994a, 1994b; Ramakrishnan
et al. 1999). Most studies have evaluated
women well after the pregnancy has been
established and the woman knows she is preg-
nant, typically during the second or third
trimester. In contrast, the effect of a woman’s
nutritional status prior to pregnancy and dur-
ing the ﬁrst trimester on pregnancy outcomes
has been rarely studied, even though evidence
suggests that this is a vulnerable period in
embryo and fetal development (Ashworth and
Antipatis 2001; Czeizel 1995; Robinson et al.
1999). Studying women’s nutritional status
during this period will help determine the
impact of early nutritional deficiencies or
excesses on birth outcomes, and thereby assist
in prevention efforts by enabling the design of
more timely interventions.
Pregnancy is a time of increased cellular
metabolism and rapid growth and develop-
ment; therefore, there is an increased demand
for energy and nutrients during pregnancy
(King 2000). Changes in nutritional metabo-
lism are driven by hormonal changes, fetal
demands, and maternal nutritional supply. In
general, well-nourished women need only a
small amount of additional energy because of
physiologic adaptations such as a lowered basal
metabolic rate and reduced physical activity.
However, these adaptations are limited in their
capacity to adjust to changes in nutritional
metabolism such that maternal undernutrition
or micronutrient deﬁciencies or excesses during
a critical stage of development may compro-
mise fetal growth and development.
Nutritional requirements vary over the
course of the pregnancy, depending on the
stage of prenatal development. A woman’s
nutritional status prior to pregnancy, measured
by prepregnancy weight, has been signiﬁcantly
associated with intrauterine growth retardation
(weight for gestational age at birth < 10th per-
centile of a reference population) and low birth
weight (< 2.5 kg) (WHO 1995). Higher
maternal body mass index before pregnancy
has been associated with a lower risk of having
a small-for-gestational-age infant and an
increased risk of late fetal death and NTDs
(Cnattingius et al. 1998; Werler et al. 1996).
Improving women’s nutritional status in the
months prior to pregnancy has resulted in
higher birth weights and lengths (Caan et al.
1987). Data from the Collaborative Perinatal
Project, a study of more than 55,000 pregnan-
cies, found that maternal prepregnancy weight
and gestational weight gain act independently
of each other but are additive in their effect on
fetal growth (Luke 1994b). It has been hypoth-
esized that poor periconceptional nutrition
may adversely affect placental growth, leading
to insufﬁcient fetoplacental exchange of nutri-
ents, or that underlying micronutrient defi-
ciency such as iron deﬁciency or anemia may
stimulate the hypothalamic–pituitary–adrenal
axis, thereby affecting early growth and length
of gestation (Allen 2001; Robinson et al.
1995). A better understanding of the effects of
preconceptional nutritional deficits (or
excesses) and their causal mechanisms could
lead to more effective interventions to reduce
these fetal exposures and could help separate
xenobiotic etiologies from nutritional causes of
ill health.
Although nutrient requirements during
early pregnancy are quantitatively small, spe-
ciﬁc nutritional deﬁciencies and toxicities can
have adverse effects on prenatal development.
During the first 2 weeks postovulation,
maternal protein deﬁciency is associated with
a variety of adverse pregnancy outcomes in
animal studies (Desai et al. 1996; Gressens
et al. 1997; Langley-Evans 2000). One such
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low protein diet during preimplantation and
then a normal control diet for the remainder
of pregnancy had lower birth weights,
increased growth rate postweaning, increased
systolic blood pressure, and disproportionate
growth of the liver and kidneys compared
with control offspring (Kwong et al. 2000).
Much of what we know about the importance
of preimplantation nutrition in humans we
have learned from human in vitro fertilization
studies that suggest that certain amino acids
(among other essential nutrients) are neces-
sary substrates for the development and
viability of the conceptus posttransfer
(Conaghan et al. 1998; Devreker et al. 2001).
Although evidence from human epidemio-
logic studies is not sufﬁcient to conclude that
there is a relationship between low protein
intake in pregnancy and pregnancy outcomes
(Metges 2001), studies of pregnant women
exposed to extreme food deprivation suggest
that this may be a vulnerable period in
human development as well (Susser and Stein
1994). Specifically, women deprived during
the 3-week period beginning after menstrua-
tion through implantation were more likely
to have infertility problems and/or an infant
born with an NTD. Those exposed in utero
were more likely to have schizophrenia and
schizoid and antisocial personality at 19 years
of age.
During embryogenesis, the period of
development from the third through eighth
postovulatory weeks, an inappropriate dietary
supply, a functional deficiency, or an excess
amount of a micronutrient can be terato-
genic. Although the causal mechanisms are
not well understood in some cases, micro-
nutrients are integral components of cellular
metabolism. As such, micronutrients have the
potential to impair cellular growth and repli-
cation in the rapidly growing embryo and
fetus. Perhaps the best-known example of the
impact of a micronutrient during this vulner-
able period of development is the relation
between folic acid deficiency and NTDs. In
the last decade, periconceptional folic acid
supplementation has been shown to prevent
the occurrence and recurrence of NTDs
(Lumley et al. 2002). NTDs occur within the
ﬁrst month after conception and are thought
to be caused by failure of the neural tube to
close (Sadler 1998). However, the mechanism
by which folic acid prevents NTDs is
unknown, and folic acid does not prevent all
NTDs. Studies have suggested that the etiol-
ogy of NTDs may be multifactorial, and deﬁ-
ciencies in other nutrients such as zinc,
methionine, vitamin B12, and selenium may
be involved (Guvenc et al. 1995; Kirke et al.
1993; Shoob et al. 2001; Velie et al. 1999).
Excessive levels of micronutrients have also
been associated with NTDs (e.g., vitamin A)
(Rothman et al. 1995). In addition, there is
increasing evidence that inadequate micro-
nutrient status during organogenesis may be
associated with an increased risk for other
congenital anomalies such as orofacial clefts,
conotruncal cardiac defects, and defects of the
urinary system, as evidenced by reduced risk
of these anomalies with periconceptional
multivitamin supplementation (Botto et al.
1996; Czeizel 1996; Hall and Solehdin 1998;
Itikala et al. 2001).
Micronutrient deﬁciencies have also been
associated with adverse pregnancy outcomes
such as preterm delivery (gestation < 37
weeks) and low birth weight. A recent review
found an association between maternal ane-
mia (i.e., low hemoglobin concentration) and
these outcomes (Rasmussen 2001), but the
majority of these studies document only the
effect of second-trimester anemia. A few stud-
ies have found an association between first-
trimester anemia and preterm delivery
(Scanlon et al. 2000; Scholl and Reilly 2000;
Zhou et al. 1998). Although anemia is the
most commonly used indicator for iron deﬁ-
ciency, iron deficiency is rarely assessed in
pregnancy, and anemia is neither a sensitive
nor specific indicator for iron deficiency.
Some evidence suggests that iron deficiency
anemia is associated with an increased risk
for preterm delivery (Lu et al. 1991; Scholl
et al. 1992), though this link is still uncon-
firmed (Rasmussen 2001). There is also
evidence that deficiencies of other micro-
nutrients such as zinc, calcium, and folic acid
may be associated with preterm delivery and
low birth weight.
Research into the area of periconceptional
nutrition has shown that maternal nutritional
deficiencies and toxicities in early pregnancy
can have irreversible effects. Greater emphasis
on research during the periconceptional
period may yield data that conﬁrm that other
nutritional deficiencies or toxicities, previ-
ously unstudied in human populations, may
affect health outcomes in the fetus, infant,
and child. For a better understanding of the
role of periconceptional nutrition on the
health of the pregnant mother, fetus, and ulti-
mately the infant, a woman’s nutritional sta-
tus should be evaluated during this critical
time of development. Because women often
do not know that they are pregnant until after
the period of organogenesis, it is critical that
any long-term study of health outcomes in
children and adolescents enroll the woman
before she becomes pregnant.
This review has focused on environmental
exposures, although there are clearly other fac-
tors that were not considered, and which we
know impact pregnancy outcome and the
child’s health, including a large number of dis-
eases (reviewed in Geist and Koren 2001) and
environmental heat (Wells and Cole 2002).
Conclusions
Even this modest data review shows that we
know a considerable amount about the rela-
tively short-term consequences of various sit-
uations that occur before and at the time of
conception. Studies have shown that numer-
ous xenobiotics are present in semen and fol-
licular ﬂuid, or circulating in maternal blood
and lodged in fat stores. The expanding ART
literature clearly documents that the environ-
ment at the time of conception can impact
the developing embryo, and thus likely affects
the long-term health of the child, and thus
affects healthcare spending and its associated
burdens. Nutrition clearly impacts the
progress of the pregnancy and the subsequent
health of the child in many known ways.
This review documents what is already
known about the determinants of children’s
health. Knowing that we only make new ﬁnd-
ings (i.e., become smarter) when we ask new
questions, the implication that cannot be
ignored is that the long-term longitudinal
National Children’s Study (2002) is our best
hope for actually testing some of the potential
effects identified in this literature, and for
identifying new associations between early
exposures and later health status. Only by col-
lecting biological specimens and actually
measuring what the internal exposures are in
women and men prior to and at the time of
conception will we be able to deﬁnitively say
which, if any, of these exposures are meaning-
ful. Doing this in the context of a large longi-
tudinal epidemiologic health study will help us
determine which of these exposures impacts
the health of the offspring. Knowing this can
powerfully inform future decision-making,
will create hypotheses to test and verify for
years to come, and will allow regulatory efforts
to focus on those exposures that have the
greatest impact. This is a chance that must not
be missed.
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